Abajobir, A. A., Najman, J. M., Williams, G., Strathearn, L., Clavarino, A., & Kisely, S. (2017). Substantiated childhood maltreatment and young adulthood cannabis use disorders: A pre-birth cohort study. Psychiatry Research, 256, 21-31. https://doi.org/10.1016/j.psychres.2017.06.017
Abrams, D. I. (2016). Integrating cannabis into clinical cancer care. Current Oncology (Toronto), 23(2), S8-14. https://doi.org/10.3747/co.23.3099
Abrams, D. I. (2018). The therapeutic effects of cannabis and cannabinoids: An update from the national academies of sciences, engineering and medicine report. European Journal of Internal Medicine, 49, 7-11. https://doi.org/10.1016/j.ejim.2018.01.003
Abulseoud, O. A., Zuccoli, M. L., Zhang, L., Barnes, A., Huestis, M. A., & Lin, D. (2017). The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. European Neuropsychopharmacology, 27(7), 679-690. https://doi.org/10.1016/j.euroneuro.2017.03.006
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596
Andreae, M. H., Carter, G. M., Shaparin, N., Suslov, K., Ellis, R. J., Ware, M. A., Abrams, D. I., Prasad, H., Wilsey, B., Indyk, D., Johnson, M., & Sacks, H. S. (2015). Inhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. The Journal of Pain, 16(12), 1221-1232. https://doi.org/10.1016/j.jpain.2015.07.009
Babson, K. A., & Bonn-Miller, M. O. (2014). Sleep disturbances: Implications for cannabis use, cannabis use cessation, and cannabis use treatment. Current Addiction Reports, 1(2), 109-114. https://doi.org/10.1007/s40429-014-0016-9
Babson, K. A., Sottile, J., & Morabito, D. (2017). Cannabis, cannabinoids, and sleep: A review of the literature. Current Psychiatry Reports, 19(4), 1-12. https://doi.org/10.1007/s11920-017-0775-9
Bar-Sela, G., Zalman, D., Semenysty, V., & Ballan, E. (2019). The effects of dosage-controlled cannabis capsules on cancer-related cachexia and anorexia syndrome in advanced cancer patients: Pilot study. Integrative Cancer Therapies, 18, 1534735419881498. https://doi.org/10.1177/1534735419881498
Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018). Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort. Journal of Headache and Pain, 19(1), 1-28. https://doi.org/10.1186/s10194-018-0862-2
Barrus, D. G., Capogrossi, K. L., Cates, S. C., Gourdet, C. K., Peiper, N. C., Novak, S. P., Lefever, T. W., & Wiley, J. L. (2016). Tasty thc: Promises and challenges of cannabis edibles. Methods Report (RTI Press), 2016, 10.3768/rtipress.2016.op.0035.1611. https://doi.org/10.3768/rtipress.2016.op.0035.1611
BC Lung Foundation. (2019). Cannabis and Lung Health. https://bclung.ca/how-we-can-help/cannabis-and-lung-health
Beal, K. (2019). Considerations in the addition of cannabis to chocolate. Current Opinion in Food Science, 28, 14-17. https://doi.org/10.1016/j.cofs.2019.02.007
Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A., Irving, A. J., Katona, I., Yanagawa, Y., Rakic, P., Lutz, B., Mackie, K., & Harkany, T. (2007). Hardwiring the brain: Endocannabinoids shape neuronal connectivity. Science (New York, N.Y.), 316(5828), 1212-1216. https://doi.org/10.1126/science.1137406
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., O'Carroll, C., Crippa, J., Atakan, Z., & McGuire, P. (2009). P. 3.02 Opposite neural effects of the main psychoactive ingredients of cannabis—implications for therapeutics. European Neuropsychopharmacology, 19, S63-S64. https://doi.org/10.1016/S0924-977X(09)70072-0
Blake, A., & Nahtigal, I. (2019). The evolving landscape of cannabis edibles. Current Opinion in Food Science, 28, 25-31. https://doi.org/10.1016/j.cofs.2019.03.009
Boden, M. T., Babson, K. A., Vujanovic, A. A., Short, N. A., & Bonn-Miller, M. O. (2013). Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. The American Journal on Addictions, 22(3), 277-284. https://doi.org/10.1111/j.1521-0391.2012.12018.x
Bolanis, D., Orri, M., Castellanos-Ryan, N., Renaud, J., Montreuil, T., Boivin, M., Vitaro, F., Tremblay, R. E., Turecki, G., Cote, S. M., Seguin, J. R., & Geoffroy, M. C. (2020). Cannabis use, depression and suicidal ideation in adolescence: direction of associations in a population based cohort. Journal of Affective Disorders, 274, 1076-1083. https://doi.org/10.1016/j.jad.2020.05.136
Bonn-Miller, M. O., Babson, K. A., & Vandrey, R. (2013;2014;). Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with ptsd. Drug and Alcohol Dependence, 136, 162-165. https://doi.org/10.1016/j.drugalcdep.2013.12.008
Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J., & Williams, C. M. (2016).Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 233(19), 3603-3613. https://doi.org/10.1007/s00213-016-4397-4
Brubacher, J. R., Chan, H., & Staples, J. A. (2020). Cannabis-impaired driving and canadian youth. Paediatrics & Child Health, 25(Supplement_1), S21-S25. https://doi.org/10.1093/pch/pxaa017
Buckner, J. D., Jeffries, E. R., Crosby, R. D., Zvolensky, M. J., Cavanaugh, C. E., & Wonderlich, S. A. (2018). The impact of ptsd clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment. The American Journal of Drug & Alcohol Abuse, 44(5), 532–542. https://doi.org/10.1080/00952990.2018.1430149
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. The American Journal of Psychiatry, 161(11), 1967-1977. https://doi.org/10.1176/appi.ajp.161.11.1967
Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003). The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology, 112(3), 393–402. https://doi.org/10.1037/0021-843X.112.3.393
Budney, A. J., Sargent, J. D., & Lee, D. C. (2015). Vaping cannabis (marijuana): Parallel concerns to e‐cigs? Addiction (Abingdon, England), 110(11), 1699-1704. https://doi.org/10.1111/add.13036
Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019). Cannabis effects on brain structure, function, and cognition: Considerations for medical uses of cannabis and its derivatives. The American Journal of Drug and Alcohol Abuse, 45(6), 563-579. https://doi.org/10.1080/00952990.2019.1634086
Butterworth, P., Slade, T., & Degenhardt, L. (2014). Factors associated with the timing and onset of cannabis use and cannabis use disorder: Results from the 2007 australian national survey of mental health and well‐being. Drug and Alcohol Review, 33(5), 555-564. https://doi.org/10.1111/dar.12183
Capler, R. (2009). Why people use cannabis. Visions: BC’s Mental Health and Substance Use Journal, 5(4), 9. https://www.heretohelp.bc.ca/why-people-use-cannabis
Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011). Cannabis use in youngpeople: The risk for schizophrenia. Neuroscience and Biobehavioral Reviews, 35(8), 1779-1787. https://doi.org/10.1016/j.neubiorev.2011.04.007
Chang, L., Yakupov, R., Cloak, C., & Ernst, T. (2006). Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain (London, England: 1878), 129(5), 1096-1112. https://doi.org/10.1093/brain/awl064
Chelliah, M. P., Zinn, Z., Khuu, P., & Teng, J. M. (2018). Self‐initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatric Dermatology, 35(4), e224-e227. https://doi.org/10.1111/pde.13545
Chinnappa, N. B., Zalewska, K., & Mckeon, D. (2014). P60 cannabis lung causing debilitating emphysema: Are we on the verge of an epidemic? Thorax, 69(Suppl 2), A101-A101. https://doi.org/10.1136/thoraxjnl-2014-206260.201
Colizzi, M., McGuire, P., Giampietro, V., Williams, S., Brammer, M., & Bhattacharyya, S. (2018). Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing. Experimental and Clinical Psychopharmacology, 26(6), 582-598. https://doi.org/10.1037/pha0000221
Colizzi, M., Tosato, S., & Ruggeri, M. (2020). Cannabis and cognition: Connecting the dots towards the understanding of the relationship. Brain Sciences, 10(3), 133. https://doi.org/10.3390/brainsci10030133
Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012). Smoked cannabis for spasticity in multiple sclerosis: A randomized, placebo-controlled trial. Canadian Medical Association Journal (CMAJ), 184(10), 1143-1150. https://doi.org/10.1503/cmaj.110837
Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2014). Effect of baseline cannabis use and working‐memory network function on changes in cannabis use in heavy cannabis users: A prospective fMRI study. Human Brain Mapping, 35(5), 2470-2482. https://doi.org/10.1002/hbm.22342
Crippa, J. A., Zuardi, A. W., Martín-Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar-Poli, P. (2009). Cannabis and anxiety: A critical review of the evidence. Human Psychopharmacology, 24(7), 515-523. https://doi.org/10.1002/hup.1048
Curry, B., & Gould, S. (2018). Scoping review: Medicinal benefits of cannabis related to stimulating appetite in populations at risk for nutritional deficiency. Journal of the Academy of Nutrition and Dietetics, 118(10), A123-A123. https://doi.org/10.1016/j.jand.2018.08.015
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29(8), 1558-1572. https://doi.org/10.1038/sj.npp.1300496
Dahlgren, M. K., Sagar, K. A., Smith, R. T., Lambros, A. M., Kuppe, M. K., & Gruber, S. A. (2020). Recreational cannabis use impairs driving performance in the absence of acute intoxication. Drug and Alcohol Dependence, 208, 107771. https://doi.org/10.1016/j.drugalcdep.2019.107771
Danielsson, A. K., Lundin, A., Agardh, E., Allebeck, P., & Forsell, Y. (2016). Cannabis use, depression and anxiety: A 3-year prospective population-based study. Journal of Affective Disorders, 193, 103-108. https://doi.org/10.1016/j.jad.2015.12.045
Davis, G. P., Compton, M. T., Wang, S., Levin, F. R., & Blanco, C. (2013). Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the national epidemiologic survey on alcohol and related conditions. Schizophrenia Research, 151(1), 197-202. https://doi.org/10.1016/j.schres.2013.10.018
De Aquino, J. P., Sofuoglu, M., Stefanovics, E. A., & Rosenheck, R. A. (2020). Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: A nationwide longitudinal va study. The American Journal of Drug and Alcohol Abuse, 46(6), 812-822. https://doi.org/10.1080/00952990.2020.1818248
Defoe, I. N., Khurana, A., Betancourt, L. M., Hurt, H., & Romer, D. (2019). Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: Developmental cascading links to cannabis use disorder. Addiction (Abingdon, England), 114(3), 485–493. https://doi.org/10.1111/add.14456
Degenhardt, L., Hall, W., & Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98(11), 1493-1504. https://doi.org/10.1046/j.1360-0443.2003.00437.x
Denson, T. F., & Earleywine, M. (2006). Decreased depression in marijuana users. Addictive Behaviors, 31(4), 738-742. https://doi.org/10.1016/j.addbeh.2005.05.052
Donoghue, K., Doody, G. A., Murray, R. M., Jones, P. B., Morgan, C., Dazzan, P., Hart, J., Mazzoncini, R., & MacCabe, J. H. (2014). Cannabis use, gender and age of onset of schizophrenia: Data from the ÆSOP study. Psychiatry Research, 215(3), 528-532. https://doi.org/10.1016/j.psychres.2013.12.038
Drummer, O. H., Gerostamoulos, D., & Woodford, N. W. (2019). Cannabis as a cause of death: A review. Forensic Science International, 298, 298-306. https://doi.org/10.1016/j.forsciint.2019.03.007
Duncan, A. E., Sartor, C. E., Scherrer, J. F., Grant, J. D., Heath, A. C., Nelson, E. C., Jacob, T., & Bucholz, K. K. (2008). The association between cannabis abuse and dependence and childhood physical and sexual abuse: Evidence from an offspring of twins design. Addiction, 103(6), 990-997. https://doi.org/10.1111/j.1360-0443.2008.02210.x
Duran, M., Pérez, E., Abanades, S., Vidal, X., Saura, C., Majem, M., Arriola, E., Rabanal, M., Pastor, A., Farre, M., Rams, N., Laporte, J. R., & Capellà, D. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting. British Journal of Clinical Pharmacology, 70(5), 656-663. https://doi.org/10.1111/j.1365-2125.2010.03743.x
Dworkin, E. R., Kaysen, D., Bedard-Gilligan, M., Rhew, I. C., & Lee, C. M. (2017). Daily-level associations between ptsd and cannabis use among young sexual minority women. Addictive Behaviors, 74, 118-121. https://doi.org/10.1016/j.addbeh.2017.06.007
Earleywine, M., & Barnwell, S. S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4(1), 11. https://doi.org/10.1186/1477-7517-4-11
Ellgren, M., Artmann, A., Tkalych, O., Gupta, A., Hansen, H.S., Hansen, S.H., Devi, L. A., & Hurd, Y. L. (2008). Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: Thc effects. European Neuropsychopharmacology, 18(11), 826-834. https://doi.org/10.1016/j.euroneuro.2008.06.009
Farokhnia, M., McDiarmid, G. R., Newmeyer, M. N., Munjal, V., Abulseoud, O. A., Huestis, M. A., & Leggio, L. (2020). Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: A randomized, double-blind, placebo-controlled, human laboratory study. Translational Psychiatry, 10(1), 71. https://doi.org/10.1038/s41398-020-0756-3
Farrimond, J. A., Whalley, B. J., & Williams, C. M. (2010). A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats. Behavioural Pharmacology, 21(8), 769-772. https://doi.org/10.1097/FBP.0b013e328340a062
Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2016). The association between cannabis use and anxiety disorders: Results from a population-based representative sample. European Neuropsychopharmacology, 26(3), 493-505. https://doi.org/10.1016/j.euroneuro.2015.12.037
Fischer, B., Jeffries, V., Hall, W., Room, R., Goldner, E., & Rehm, J. (2011). Lower risk cannabis use guidelines for canada (lrcug): A narrative review of evidence and recommendations. Canadian Journal of Public Health, 102(5), 324-327. https://doi.org/10.1007/BF03404169
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017). Lower-risk cannabis use guidelines: A comprehensive update ofevidence and recommendations. American Journal of Public Health (1971), 107(8), E1-E12. https://doi.org/10.2105/AJPH.2017.303818
Gaffal, E., Cron, M., Glodde, N., & Tüting, T. (2013). Anti‐inflammatory activity of topical thc in dnfb‐mediated mouse allergic contact dermatitis independent of cb1 and cb2 receptors. Allergy, 68(8), 994-1000. https://doi.org/10.1111/all.12183
Gage, S. H., Jones, H. J., Burgess, S., Bowden, J., Davey Smith, G., Zammit, S., & Munafò, M. R. (2017). Assessing causality in associations between cannabis use and schizophrenia risk: A two-sample mendelian randomization study. Psychological Medicine, 47(5), 971-980. https://doi.org/10.1017/S0033291716003172
Galli, J. A., Sawaya, R. A., & Friedenberg, F. K. (2011). Cannabinoid hyperemesis syndrome. Current Drug Abuse Reviews, 4(4), 241–249. https://doi.org/10.2174/1874473711104040241
Gates, P., Jaffe, A., & Copeland, J. (2014). Cannabis smoking and respiratory health: Consideration of the literature. Respirology (Carolton, Vic.), 19(5), 655-662. https://doi.org/10.1111/resp.12298
Gieringer, D., St. Laurent, J., & Goodrich, S. (2004). Cannabis vaporizer combines efficient delivery of thc with effective suppression of pyrolytic compounds. Journal of Cannabis Therapeutics, 4(1), 7-27. https://doi.org/10.1300/J175v04n01_02
Government of Canada. (2021). Addiction to cannabis. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/health-effects/addiction.html
Graham, V. E., & Clough, A. R. (2019). "Need everyone helping to keep off because everyone helping to keep on" - reducing harms from cannabis use in remote indigenous australian communities involves more than just users. Substance use & Misuse, 54(5), 699-712. https://doi.org/10.1080/10826084.2018.1504078
Green, B. O. B., Kavanagh, D., & Young, R. (2003). Being stoned: A review of self‐reported cannabis effects. Drug and Alcohol Review, 22(4), 453-460. https://doi.org/10.1080/09595230310001613976
Grewal, J. K., & Loh, L. C. (2020). Health considerations of the legalization of cannabis edibles. Canadian Medical Association Journal (CMAJ), 192(1), E1-E2. https://doi.org/10.1503/cmaj.191217
Griffith-Lendering, M. F. H., Wigman, J. T. W., Prince van Leeuwen, A., Huijbregts, S. C. J., Huizink, A. C., Ormel, J., Verhulst, F. C., van Os, J., Swaab, H., & Vollebergh, W. A. M. (2013). Cannabis use and vulnerability for psychosis in early adolescence - A trails study. Addiction (Abingdon, England), 108(4), 733-740.https://doi.org/10.1111/add.12050
Grotenhermen, F. (1999). The effects of cannabis and thc. Forschende Komplementarmedizin, 6 Suppl 3, 7-11. https://doi.org/10.1159/000057149
Grotenhermen, F. (2001). Harm reduction associated with inhalation and oral administration of cannabis and thc. Journal of Cannabis Therapeutics, 1(3-4), 133-152. https://doi.org/10.1300/J175v01n03_09
Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42(4), 327-360. https://doi.org/10.2165/00003088-200342040-00003
Grotenhermen, F. (2004). Cannabinoids for therapeutic use: Designing systems to increase efficacy and reliability. American Journal of Drug Delivery, 2(4), 229-240. https://doi.org/10.2165/00137696-200402040-00003
Gustavsen, S., Søndergaard, HB., Linnet, K., Thomsen, R., Rasmussen, BS., Sorensen, PS., Sellebjerg, F., & Oturai, AB. (2021). Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Multiple Sclerosis and Related Disorders, 48, 102708-102708. https://doi.org/10.1016/j.msard.2020.102708
Habboushe, J., Rubin, A., Liu, H., & Hoffman, R. S. (2018). The prevalence of cannabinoid hyperemesis syndrome among regular marijuana smokers in an urban public hospital. Basic & Clinical Pharmacology & Toxicology, 122(6), 660-662. https://doi.org/10.1111/bcpt.12962
Halladay, J. E., Boyle, M. H., Munn, C., Jack, S. M., & Georgiades, K. (2019). Sex differences in the association between cannabis use and suicidal ideation and attempts, depression, and psychological distress among canadians. Canadian Journal of Psychiatry, 64(5), 345-350. https://doi.org/10.1177/0706743718804542
Hancox, R. J., Poulton, R., Ely, M., Welch, D., Taylor, D. R., McLachlan, C. R., Greene, J. M., Moffitt, T. E., Caspi, A., & Sears, M. R. (2010). Effects of cannabis on lung function: A population-based cohort study. The European Respiratory Journal, 35(1), 42–47. https://doi.org/10.1183/09031936.00065009
Hancox, R. J., Shin, H. H., Gray, A. R., Poulton, R., & Sears, M. R. (2015). Effects of quitting cannabis on respiratory symptoms. The European Respiratory Journal, 46(1), 80-87. https://doi.org/10.1183/09031936.00228914
Harvey, M. A., Sellman, J. D., Porter, R. J., & Frampton, C. M. (2007). The relationship between non-acute adolescent cannabis use and cognition. Drug and Alcohol Review, 26(3), 309-319. https://doi.org/10.1080/09595230701247772
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016). Prevalence and correlates of dsm-5 cannabis use disorder, 2012-2013: Findings from the national epidemiologic survey on alcohol and related conditions–III. The American Journal of Psychiatry, 173(6), 588-599. https://doi.org/10.1176/appi.ajp.2015.15070907
Hawke, L. D., Wilkins, L., & Henderson, J. (2020). Early cannabis initiation: Substance use and mental health profiles of service-seeking youth. Journal of Adolescence, 83, 112-121. https://doi.org/10.1016/j.adolescence.2020.06.004
Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (volcano®) for the pulmonary administration of tetrahydrocannabinol. Journal of Pharmaceutical Sciences, 95(6), 1308-1317. https://doi.org/10.1002/jps.20574
Hernandez, J. M., Paty, J., & Price, I. M. (2018). Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area. Canadian Journal of Emergency Medicine, 20(4), 550- 555. https://doi.org/10.1017/cem.2017.381
Hezode, C., Roudot-Thoraval, F., Nguyen, S., Grenard, P., Julien, B., Zafrani, E., Pawlostky, J., Dhumeaux, D., Lotersztajn, S., & Mallat, A. (2005). Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis c. Hepatology (Baltimore, MD.), 42(1), 63-71. https://doi.org/10.1002/hep.20733
Hodgson, K., Coleman, J. R. I., Hagenaars, S. P., Purves, K. L., Glanville, K., Choi, S. W., O'Reilly, P., Breen, G., Lewis, C. M., & Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. (2020). Cannabis use, depression and self‐harm: Phenotypic and genetic relationships. Addiction (Abingdon, England), 115(3), 482-492. https://doi.org/10.1111/add.14845
Horwood, L. J., Fergusson, D. M., Coffey, C., Patton, G. C., Tait, R., Smart, D., Letcher, P., Silins, E., & Hutchinson, D. M. (2012). Cannabis and depression: An integrative data analysis of four australasian cohorts. Drug and Alcohol Dependence, 126(3), 369-378. https://doi.org/10.1016/j.drugalcdep.2012.06.002
Jager, G., Kahn, R. S., Van Den Brink, W., Van Ree, J.,M., & Ramsey, N. F. (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology, 185(3), 358-68. https://doi.org/10.1007/s00213-005-0298-7
Jager, G., Van Hell, H. H., De Win, M. M., Kahn, R.S., Van Den Brink, W., Van Ree, J. M., Ramsey, N. F. (2007). Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology, 17(4), 289-297. https://doi.org/10.1016/j.euroneuro.2006.10.003
Jennings, J. M., Johnson, R. M., Brady, A. C., & Dennis, D. A. (2020). Patient perception regarding potential effectiveness of cannabis for pain management. The Journal of Arthroplasty, 35(12), 3524-3527. https://doi.org/10.1016/j.arth.2020.06.051
Johnson, M. J., Pierce, J. D., Mavandadi, S., Klaus, J., Defelice, D., Ingram, E., & Oslin, D. W. (2015;2016;). Mental health symptom severity in cannabis using and non-using veterans with probable ptsd. Journal of Affective Disorders, 190, 439-442. https://doi.org/10.1016/j.jad.2015.10.048
Johnson, S. B., Blum, R. W., & Giedd, J. N. (2009). Adolescent maturity and the brain: The promise and pitfalls of neuroscience research in adolescent health policy. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, 45(3), 216–221. https://doi.org/10.1016/j.jadohealth.2009.05.016
Jones, C. B., Meier, M. H., & Pardini, D. A. (2018). Comparison of the locations where young adults smoke, vape, and eat/drink cannabis: Implications for harm reduction. Addictive Behaviors Reports, 8, 140-146. https://doi.org/10.1016/j.abrep.2018.09.002
Joshi, M., Joshi, A., & Bartter, T. (2014). Marijuana and lung diseases. Current Opinion in Pulmonary Medicine, 20(2), 173-179. https://doi.org/10.1097/MCP.0000000000000026
Kanayama, G., Rogowska, J., Pope, H. G., Gruber, S. A., & Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology, 176(3), 239-247. https://doi.org/10.1007/s00213-004-1885-8
Kedzior, K. K., & Laeber, L. T. (2014). A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies. BMC Psychiatry, 14(1), 136. https://doi.org/10.1186/1471-244X-14-136
Kevorkian, S., Bonn-Miller, M. O., Belendiuk, K., Carney, D. M., Roberson-Nay, R., & Berenz, E. C. (2015). Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychology of Addictive Behaviors, 29(3), 633. https://doi.org/10.1037/adb0000110
Khalili, M. A., & Rasulzadeh, M. (2011). Spasticity: A review of methods for assessment and treatment. Iranian Rehabilitation Journal, 9(14), 60-64. http://irj.uswr.ac.ir/article-1-262-en.pdf
King, C., & Holmes, A. (2015). Cannabinoid hyperemesis syndrome. Canadian Medical Association Journal (CMAJ), 187(5), 355. https://doi.org/10.1503/cmaj.140154
Koppel, B. S., Brust, J. C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., & Gloss, D. (2014). Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 82(17), 1556-1563. https://doi.org/10.1212/WNL.0000000000000363
Kosiba, J. D., Maisto, S. A., & Ditre, J. W. (2019). Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis. Social Science & Medicine (1982), 233, 181-192. https://doi.org/10.1016/j.socscimed.2019.06.005
Koskinen, J., Lohonen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: A meta-analysis. Schizophrenia Bulletin, 36(6), 1115-1130.https://doi.org/10.1093/schbul/sbp031
Kroon, E., Kuhns, L., Hoch, E., & Cousijn, J. (2020). Heavy cannabis use, dependence and the brain: A clinical perspective. Addiction (Abingdon, England), 115(3), 559-572. https://doi.org/10.1111/add.14776
Lamy, F. R., Daniulaityte, R., Sheth, A., Nahhas, R. W., Martins, S. S., Boyer, E. W., & Carlson, R. G. (2016). “Those edibles hit hard”: Exploration of twitter data on cannabisedibles in the u.s. Drug and Alcohol Dependence, 164, 64-70. https://doi.org/10.1016/j.drugalcdep.2016.04.029
Lau, N., Sales, P., Averill, S., Murphy, F., Sato, S. O., & Murphy, S. (2015). Responsible and controlled use: Older cannabis users and harm reduction. The International Journal of Drug Policy, 26(8), 709-718. https://doi.org/10.1016/j.drugpo.2015.03.008
Leberl, M., Kratzer, A., & Taraseviciene-Stewart, L. (2013). Tobacco smoke induced copd/emphysema in the animal model—are we all on the same page? Frontiers in Physiology, 4, 91-91. https://doi.org/10.3389/fphys.2013.00091
Lee, C. M., Neighbors, C., & Woods, B. A. (2007). Marijuana motives: Young adults' reasons for using marijuana. Addictive behaviors, 32(7), 1384-1394. https://doi.org/10.1016/j.addbeh.2006.09.010
Lee, D. C., Crosier, B. S., Borodovsky, J. T., Sargent, J. D., & Budney, A. J. (2016). Online survey characterizing vaporizer use among cannabis users. Drug and Alcohol Dependence, 159, 227-233. https://doi.org/10.1016/j.drugalcdep.2015.12.020
Lee, M. H., & Hancox, R. J. (2011). Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine, 5(4), 537-46. https://doi.org/10.1586/ers.11.40
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44(4), 797-810. https://doi.org/10.1017/S0033291713001438
Levy, J., Buhl, K., Fernandez, C., & Jayaram, K. (2020). Does smoking cannabis increase the risk of barrett’s esophagus? Cureus (Palo Alto, CA), 12(2), e6913. https://doi.org/10.7759/cureus.6913
Li, X., Vigil, J. M., Stith, S. S., Brockelman, F., Keeling, K., & Hall, B. (2019). The effectiveness of self-directed medical cannabis treatment for pain. Complementary Therapies in Medicine, 46, 123-130. https://doi.org/10.1016/j.ctim.2019.07.022
Livne, O., Shmulewitz, D., Lev-Ran, S., & Hasin, D. S. (2019). Dsm-5 cannabis withdrawal syndrome: Demographic and clinical correlates in u.s. adults. Drug and Alcohol Dependence, 195, 170-177.https://doi.org/10.1016/j.drugalcdep.2018.09.005
Loflin, M., & Earleywine, M. (2015). No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Canadian Journal of Respiratory Therapy: CJRT, 51(1), 7-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Lopez-Quintero, C., Cobos, José Pérez de los, Hasin, D. S., Okuda, M., Wang, S., Grant, B. F., & Blanco, C. (2010;2011;). Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the national epidemiologic survey on alcohol and related conditions (nesarc). Drug and Alcohol Dependence, 115(1), 120-130. https://doi.org/10.1016/j.drugalcdep.2010.11.004
Luque, J. S., Okere, A. N., Reyes-Ortiz, C. A., & Williams, P. M. (2021). Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in florida. Complementary Therapies in Medicine, 57, 102669. https://doi.org/10.1016/j.ctim.2021.102669
Maida, V., & Corban, J. (2017). Topical medical cannabis: A new treatment for wound pain—three cases of pyoderma gangrenosum. Journal of Pain and Symptom Management, 54(5), 732-736. https://doi.org/10.1016/j.jpainsymman.2017.06.005
Maida, V., Shi, R. B., Fazzari, F. G. T., & Zomparelli, L. (2021). Topical cannabis-based medicines - A novel adjuvant treatment for venous leg ulcers: An open-label trial. Experimental Dermatology, 30(9), 1258-1267. https://doi.org/10.1111/exd.14395
Malone, D. T., Hill, M. N., & Rubino, T. (2010). Adolescent cannabis use and psychosis: Epidemiology and neurodevelopmental models. British journal of pharmacology, 160(3), 511-522. https://doi.org/10.1111/j.1476-5381.2010.00721.x
Martin, R., Safaee, S. D., Somsamouth, K., Mounivong, B., Sinclair, R., Bansal, S., & Singh, P. N. (2013). Mixed methods pilot study of sharing behaviors among waterpipe smokers of rural lao pdr: Implications for infectious disease transmission. International Journal of Environmental Research and Public Health, 10(6), 2120-2132. https://doi.org/10.3390/ijerph10062120
Mehra, R., Moore, B. A., Crothers, K., Tetrault, J., & Fiellin, D. A. (2006). The association between marijuana smoking and lung cancer: A systematic review. Archives of Internal Medicine, 166(13), 1359-1367. https://doi.org/10.1001/archinte.166.13.1359
Michael G. DeGroote Centre for Medicinal Cannabis Research. (2018). What effects does smoking cannabis have on the respiratory system? McMaster University MDCMCR. https://cannabisresearch.mcmaster.ca/news/2018/04/27/cannabis-smoking-and-effects-on-the-respiratory-system
Moir, D., Rickert, W. S., Levasseur, G., Larose, Y., Maertens, R., White, P., & Desjardins, S. (2008). A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chemical Research in Toxicology, 21(2), 494-502. https://doi.org/10.1021/tx700275p
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet (London, England), 370(9584), 319-328. https://doi.org/10.1016/S0140-6736(07)61162-3
Murphy, J., Houston, J. E., Shevlin, M., & Adamson, G. (2013). Childhood sexual trauma, cannabis use and psychosis: Statistically controlling for pre-trauma psychosis and psychopathology. Social Psychiatry and Psychiatric Epidemiology, 48(6), 853-861. https://doi.org/10.1007/s00127-012-0592-8
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington (DC): National Academies Press (US); 2017 Jan 12. https://doi.org/10.17226/24625
National Institute of Mental Health. (n.d.). What is psychosis? https://www.nimh.nih.gov/health/topics/schizophrenia/raise/what-is-psychosis
Nicholson, A. N., Turner, C., Stone, B. M., & Robson, P. J. (2004). Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Psychopharmacology, 24(3), 305-313. https://doi.org/10.1097/01.jcp.0000125688.05091.8f
Nugent, S. M., Morasco, B. J., O'Neil, M. E., Freeman, M., Low, A., Kondo, K., Elven, C., Zakher, B., Motu’apuaka, M., Paynter, R., & Kansagara, D. (2017). The effects of cannabis among adults with chronic pain and an overview of general harms: A systematic review. Annals of Internal Medicine, 167(5), 319-331. https://doi.org/10.7326/M17-0155
Ogeil, R. P., Cheetham, A., Mooney, A., Allen, N. B., Schwartz, O., Byrne, M. L., Simmons, J. G., Whittle, S., & Lubman, D. I. (2019). Early adolescent drinking and cannabis use predicts later sleep-quality problems. Psychology of Addictive Behaviors, 33(3), 266- 273. https://doi.org/10.1037/adb0000453
Ogeil, R. P., Phillips, J. G., Rajaratnam, S. M., & Broadbear, J. H. (2015). Risky drug use and effects on sleep quality and daytime sleepiness. Human Psychopharmacology: Clinical and Experimental, 30(5), 356-363. https://doi.org/10.1002/hup.2483
Ogle, W., Coppen, L., & Copriviza, C. (2020). Beyond the runners high: Cannabis and exercise: 2311 board# 230 may 28 2: 00 PM-3: 30 PM. Medicine & Science in Sports & Exercise, 52(7S), 621. https://doi.org/10.1249/01.mss.0000681040.70825.cc
Osborne, G. B., & Fogel, C. (2008). Understanding the motivations for recreational marijuana use among adult canadians. Substance use & Misuse, 43(3-4), 539-587. https://doi.org/10.1080/10826080701884911
Papatheodorou, S.I., Buettner, H., Rice, M.B., & Mittleman, M.A. (2016). Recent marijuana use and associations with exhaled nitric oxide and pulmonary function in adults in the united states. Chest, 149(6), 1428-1435. https://doi.org/10.1016/j.chest.2015.12.033
Park, J. Y., & Wu, L. T. (2017). Prevalence, reasons, perceived effects, and correlates ofmedical marijuana use: A review. Drug and Alcohol Dependence, 177, 1-13. https://doi.org/10.1016/j.drugalcdep.2017.03.009
Patel, S., Khan, S., Saipavankumar, M., & Pousettef, H. (2020). The association between cannabis use and schizophrenia: Causative or curative? A systematic review. Cureus, 12(7), e9309. https://doi.org/10.7759/cureus.9309
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002). Cannabis use and mental health in young people: Cohort study. BMJ (Clinical Research Ed.), 325(7374), 1195-1198. https://doi.org/10.1136/bmj.325.7374.1195
Pergolizzi Jr, J. V., LeQuang, J. A., & Bisney, J. F. (2018). Cannabinoid hyperemesis. Medical Cannabis and Cannabinoids, 1(2), 73-95. https://doi.org/10.1159/000494992
Pope Jr, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D.(2003). Early-onset cannabis use and cognitive deficits: What is the nature of the association? Drug and Alcohol Dependence, 69(3), 303-310. https://doi.org/10.1016/s0376-8716(02)00334-4
Power, R. A., Verweij, K. J. H., Zuhair, M., Montgomery, G. W., Henders, A. K., Heath, A. C., Madden, P. A. F., Medland, S. E., Wray, N. R., & Martin, N. G. (2014). Genetic predisposition to schizophrenia associated with increased use of cannabis. Molecular Psychiatry, 19(11), 1201-1204. https://doi.org/10.1038/mp.2014.51
Pratt, M., Stevens, A., Thuku, M., Butler, C., Skidmore, B., Wieland, L. S., Clemons, M., Kanji, S., & Hutton, B. (2019). Benefits and harms of medical cannabis: A scoping review of systematic reviews. Systematic Reviews, 8(1), 320-320. https://doi.org/10.1186/s13643-019-1243-x
Reilly, D., Didcott, P., Swift, W., & Hall, W. (1998). Long‐term cannabis use: Characteristics of users in an australian rural area. Addiction (Abingdon, England), 93(6), 837-846. https://doi.org/10.1046/j.1360-0443.1998.9368375.x
Riggs, P. K., Vaida, F., Rossi, S. S., Sorkin, L. S., Gouaux, B., Grant, I., & Ellis, R. J. (2012). A pilot study of the effects of cannabis on appetite hormones in hiv-infected adult men. Brain Research, 1431, 46-52. https://doi.org/10.1016/j.brainres.2011.11.001
Roberts, C. A., Jager, G., Christiansen, P., & Kirkham, T. C. (2019). Exploring the munchies: An online survey of users’ experiences of cannabis effects on appetite and the development of a cannabinoid eating experience questionnaire. Journal of Psychopharmacology (Oxford, England), 33(9), 1149-1159. https://doi.org/10.1177/0269881119862526
Rock, E. M., Bolognini, D., Limebeer, C. L., Cascio, M. G., Anavi‐Goffer, S., Fletcher, P. J., Mechoulam, R., Pertwee, R. G., & Parker, L. A. (2012). Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐ht(1a) somatodendritic autoreceptors in the dorsal raphe nucleus. British Journal of Pharmacology, 165(8), 2620-2634. https://doi.org/10.1111/j.1476-5381.2011.01621.x
Rooke, S. E., Norberg, M. M., Copeland, J., & Swift, W. (2013). Health outcomes associated with long-term regular cannabis and tobacco smoking. Addictive Behaviors, 38(6), 2207-2213. https://doi.org/10.1016/j.addbeh.2013.01.013
Ruiz-Veguilla, M., Barrigón, M. L., Hernández, L., Rubio, J. L., Gurpegui, M., Sarramea, F., Cervilla, J., Gutiérrez, B., James, A., & Ferrin, M. (2013). Dose–response effect between cannabis use and psychosis liability in a non-clinical population: Evidence from a snowball sample. Journal of Psychiatric Research, 47(8), 1036-1043. https://doi.org/10.1016/j.jpsychires.2013.03.003
Schoeler, T., Kambeitz, J., Behlke, I., Murray, R., & Bhattacharyya, S. (2016). The effects of cannabis on memory function in users with and without a psychotic disorder: Findings from a combined meta-analysis. Psychological Medicine, 46(1), 177-188. https://doi.org/10.1017/S0033291715001646
Schreiner, A. M., & Dunn, M. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20(5), 420-429. https://doi.org/10.1037/a0029117
Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. (2020). Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. Journal of Translational Medicine, 18(1), 374. https://doi.org/10.1186/s12967-020-02518-2
Shiplo, S., Asbridge, M., Leatherdale, S. T., & Hammond, D. (2016). Medical cannabis use in canada: Vapourization and modes of delivery. Harm Reduction Journal, 13(1), 30-30. https://doi.org/10.1186/s12954-016-0119-9
Soriano-Co, M., Batke, M., & Cappell, M. S. (2010). The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: A report of eight cases in the United States. Digestive Diseases and Sciences, 55(11), 3113–3119. https://doi.org/10.1007/s10620-010-1131-7
Stefani, A., Aramini, B., Baraldi, C., Pellesi, L., Della Casa, G., Morandi, U., & Guerzoni, S. (2020). Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers: A case-control study. PloS One, 15(3), e0230419. https://doi.org/10.1371/journal.pone.0230419
Suraev, A., Hoyos, C., Mills, L., McGregor, I., Bravo, M., Arkell, T., Benson, N., & Lintzeris, N. (2019). Cannabis use patterns for sleep disorders in australia: A subanalysis of an online cross‐sectional survey. Journal of Sleep Research, 28(S1). https://doi.org/10.1111/jsr.68_12912
Tan, W. C., Lo, C., Jong, A., Xing, L., Fitzgerald, M. J., Vollmer, W. M., Buist, S. A., & Sin, D. D., Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group, & for the Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group (2009). Marijuana and chronic obstructive lung disease: A population-based study. Canadian Medical Association Journal (CMAJ), 180(8), 814-820. https://doi.org/10.1503/cmaj.081040
Taylor, D. R., Fergusson, D. M., Milne, B. J., Horwood, L. J., Moffitt, T. E., Sears, M. R., & Poulton, R. (2002). A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction (Abingdon, England), 97(8), 1055–1061. https://doi.org/10.1046/j.1360-0443.2002.00169.x
Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, & J., Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167(3), 221-228. https://doi.org/10.1001/archinte.167.3.221
Thu, K., Hayes, M., Miles, S., Tierney, L., & Foy, A. (2013). Marijuana ‘bong’ smoking and tuberculosis. Internal Medicine Journal, 43(4), 456-458. https://doi.org/10.1111/imj.12089
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. BMG (Clinical Research Ed.), 323(7303), 16-21. https://doi.org/10.1136/bmj.323.7303.16
Tringale, R., & Jensen, C. (2011). Cannabis and insomnia. http://files7.webydo.com/92/9209805/UploadedFiles/5E9EC245-448E-17B2-C7CA-21C6BDC6852D.pdf
Van Dam, N. T., & Earleywine, M. (2010). Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. The International Journal of Drug Policy, 21(6), 511-513. https://doi.org/10.1016/j.drugpo.2010.04.001
van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013). Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study. Drug and Alcohol Dependence, 133(2), 352-359. https://doi.org/10.1016/j.drugalcdep.2013.06.009
van Os, J., Bak, M., Hanssen, M., Bijl, R. V., de Graaf, R., & Verdoux, H. (2002). Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology, 156(4), 319-327. https://doi.org/10.1093/aje/kwf043
Veen, N. D., Selten, J. P., van der Tweel, I., Feller, W. G., Hoek, H. W., & Kahn, R. S. (2004). Cannabis use and age at onset of schizophrenia. The American Journal of Psychiatry, 161(3), 501-506. https://doi.org/10.1176/appi.ajp.161.3.501
Verweij, K. J. H., Abdellaoui, A., Nivard, M. G., Sainz Cort, A., Ligthart, L., Draisma, H. H. M., Minică, C. C., & International Cannabis Consortium, Gillespie, N. A., Willemsen, G., Hottenga, J. J., Boomsma, D. I., & Vink, J. M. (2017). Short communication: Genetic association between schizophrenia and cannabis use. Drug and Alcohol Dependence, 171, 117-121. https://doi.org/10.1016/j.drugalcdep.2016.09.022
Wang, X., Dow-Edwards, D., Keller, E., & Hurd, Y. L. (2003). Preferential limbic expression of the cannabinoid receptor mrna in the human fetal brain. Neuroscience, 118(3), 681-694. https://doi.org/10.1016/s0306-4522(03)00020-4
Webb, C. W., & Webb, S. M. (2014). Therapeutic benefits of cannabis: A patient survey. Hawai'i Journal of Medicine & Public Health, 73(4), 109-111. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., Schmidlkofer, S., Westwood, M., & Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456-2473. https://doi.org/10.1001/jama.2015.6358
Winters, K. C., & Lee, C. S. (2008). Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug and Alcohol Dependence, 92(1-3), 239-247. https://doi.org/10.1016/j.drugalcdep.2007.08.005
Wittchen, H., Fröhlich, C., Behrendt, S., Günther, A., Rehm, J., Zimmermann, P., Lieb, R., & Perkonigg, A. (2007). Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug and Alcohol Dependence, 88 Suppl 1, S60-S70. https://doi.org/10.1016/j.drugalcdep.2006.12.013
Wu, J. H. (2014). Evidence brief: Communicable disease impacts of sharing electronic-cigarettes with drip tips. Public Health Ontario. https://www.publichealthontario.ca/-/media/documents/e/2014/eb-ecig-communicable-driptip.pdf?la=en
Wu, T. C., Tashkin, D. P., Djahed, B., & Rose, J. E. (1988). Pulmonary hazards of smoking marijuana as compared with tobacco. The New England Journal of Medicine, 318(6), 347–351. https://doi.org/10.1056/NEJM198802113180603
Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., Reid, M. A., Gonzalez, R., Robinson, J. L., Laird, A. R., & Sutherland, M. T. (2018). Neuroimaging meta-analysis of cannabis use studies reveals convergent functional alterations in brain regions supporting cognitive control and reward processing. Journal of Psychopharmacology (Oxford, England), 32(3), 283–295. https://doi.org/10.1177/0269881117744995
Zhang, L. R., Morgenstern, H., Greenland, S., Chang, S., Lazarus, P., Teare, M. D., Woll, P. J., Orlow, I., Cox, B., Brhane, Y., Liu, G., Hung, R. J., & on behalf of the Cannabis and Respiratory Disease Research Group of New Zealand. (2015). Cannabis smoking and lung cancer risk: Pooled analysis in the international lung cancer consortium: Cannabis smoking and lung cancer. International Journal of Cancer, 136(4), 894-903. https://doi.org/10.1002/ijc.29036
Zhou, E. S., Nayak, M. M., Chai, P. R., & Braun, I. M. (2021). Cancer patient’s attitudes of using medicinal cannabis for sleep. Journal of Psychosocial Oncology, 1-7. https://doi.org/10.1080/07347332.2021.1910396